These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 17259197)

  • 1. Challenges ahead for federal technology assessment.
    Neumann PJ
    Health Aff (Millwood); 2007; 26(2):w150-2. PubMed ID: 17259197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reflections on science, judgment, and value in evidence-based decision making: a conversation with David Eddy by Sean R. Tunis.
    Eddy D
    Health Aff (Millwood); 2007; 26(4):w500-15. PubMed ID: 17580317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of technology assessment in health benefits coverage for medical devices.
    Braslow NM; Shatin D; McCarthy DB; Newcomer LN
    Am J Manag Care; 1998 Sep; 4 Spec No():SP139-50. PubMed ID: 10185990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Policy formulation and technology assessment.
    Banta HD; Behney CJ
    Milbank Mem Fund Q Health Soc; 1981; 59(3):445-79. PubMed ID: 6792555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technology assessment and coverage decision making.
    McGivney WT
    AAPPO J; 1994; 4(5):11-2, 14-7. PubMed ID: 10150666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis and formulary decision making in England: findings from research.
    Williams IP; Bryan S
    Soc Sci Med; 2007 Nov; 65(10):2116-29. PubMed ID: 17698271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Joint report of the Council on Scientific Affairs and the Council on Medical Service. Technology assessment in medicine.
    Arch Intern Med; 1992 Jan; 152(1):46-50. PubMed ID: 1728928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technology assessment, coverage decisions, and conflict: the role of guidelines.
    Sheingold SH
    Am J Manag Care; 1998 Sep; 4 Spec No():SP117-25. PubMed ID: 10185988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing medical technology assessment: past, present, and future.
    Foote SB
    Milbank Q; 1987; 65(1):59-80. PubMed ID: 3600552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness and evidence evaluation as criteria for coverage policy.
    Garber AM
    Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-284-96. PubMed ID: 15451997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The medical expenditure panel survey: a national information resource to support healthcare cost research and inform policy and practice.
    Cohen JW; Cohen SB; Banthin JS
    Med Care; 2009 Jul; 47(7 Suppl 1):S44-50. PubMed ID: 19536015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does providing cost-effectiveness information change coverage priorities for citizens acting as social decision makers?
    Gold MR; Franks P; Siegelberg T; Sofaer S
    Health Policy; 2007 Sep; 83(1):65-72. PubMed ID: 17204347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Key principles for the improved conduct of health technology assessments for resource allocation decisions.
    Drummond MF; Schwartz JS; Jönsson B; Luce BR; Neumann PJ; Siebert U; Sullivan SD
    Int J Technol Assess Health Care; 2008; 24(3):244-58; discussion 362-8. PubMed ID: 18601792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The limited regulatory potential of medical technology assessment.
    Elhauge E
    Va Law Rev; 1996 Nov; 82(8):1525-1622. PubMed ID: 16715565
    [No Abstract]   [Full Text] [Related]  

  • 15. How should cost-effectiveness analysis be used in health technology coverage decisions? Evidence from the National Institute for Health and Clinical Excellence approach.
    Williams I; Bryan S; McIver S
    J Health Serv Res Policy; 2007 Apr; 12(2):73-9. PubMed ID: 17407655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicare and cost-effectiveness analysis.
    Neumann PJ; Rosen AB; Weinstein MC
    N Engl J Med; 2005 Oct; 353(14):1516-22. PubMed ID: 16207857
    [No Abstract]   [Full Text] [Related]  

  • 17. Federal Policy toward health care technology: the case of the National Center.
    Blumenthal D
    Milbank Mem Fund Q Health Soc; 1983; 61(4):584-613. PubMed ID: 6557372
    [No Abstract]   [Full Text] [Related]  

  • 18. Decisions to adopt new technologies at the hospital level: insights from Israeli medical centers.
    Greenberg D; Peterburg Y; Vekstein D; Pliskin JS
    Int J Technol Assess Health Care; 2005; 21(2):219-27. PubMed ID: 15921062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unmanaged care: towards moral fairness in health care coverage.
    Hoffman S
    Indiana Law J; 2003; 78(2):659-721. PubMed ID: 15214342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring policy-makers' perspectives on disinvestment from ineffective healthcare practices.
    Elshaug AG; Hiller JE; Moss JR
    Int J Technol Assess Health Care; 2008; 24(1):1-9. PubMed ID: 18218163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.